In CRC, the main molecular markers available for active targeting are the carcinoembrionic antigen (CEA) [26], the folate receptor alpha (FRα), and the epidermal growth factor receptor (EGFR and HER2) present onto the tumor cells. This evidence concerns the gene EGFR and neoplasm.